Predicting Survival Rates in Brain Metastases Patients from Non‐Small Cell Lung Cancer Using Radiomic Signatures Associated with Tumor Immune Heterogeneity
Fuxing Deng(Central South University), Rongrong Zhou(Central South University), Jiaoyang Ning(Central South University), Gang Xiao(Air Force Medical University), Liu Chen(Central South University), Zijian Zhang(South China University of Technology), Guilong Tanzhu(Central South University), Ruoyu Lu(Central South University), Xianjing Chu(Central South University)
Cited by 14
Related Papers
Cancer stem cells: advances in knowledge and implications for cancer therapy
|Signal Transduction and Targeted Therapy|2024|452
Radiomics strategy for glioma grading using texture features from multiparametric MRI
|Journal of Magnetic Resonance Imaging|2018|222
Co-inhibition of TIGIT and PD-1/PD-L1 in Cancer Immunotherapy: Mechanisms and Clinical Trials
|Molecular Cancer|2023|194
The Long-Term and Short-Term Efficacy of Immunotherapy in Non-Small Cell Lung Cancer Patients With Brain Metastases: A Systematic Review and Meta-Analysis
|Frontiers in Immunology|2022|55
<p>Growth and differentiation factor 15 regulates PD-L1 expression in glioblastoma</p>
|Cancer Management and Research|2019|33